Citations

Showing 10 of 108104 citations.

A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
Gouni, Sushanth , Crombie, Jennifer L. , Hess, Brian , Watson, Grace, Ayers, Amy , Neelapu, Sattva S. , Khurana, Arushi , Lin, Yi , Strati, Paolo , Rosenthal, Allison C, Neelapu, Sattva S , Khurana, Arushi , Strati, Paolo , Lin, Yi , Rosenthal, Allison , Ip, Andrew , Kamdar, Manali , Feng, Lei , Watson, Grace, Iqbal, Madiha , Merryman, Reid W.

Mayo Clinic

Blood Advances | March 3, 2022 | Volume: 6 | Issue: 9 | Pages: 2757-2762

10.1182/bloodadvances.2021006801 | PMID 35240681 Get It

Abstract Polatuzumab vedotin (PV) is an antibody–drug conjugate targeting CD79b that is approved for patients with relapsed/refractory large B-cell lymphoma (LBCL). Patients who relapse after chimeric antigen receptor (CAR) T-cell therapy were not included in the registration study, and reports of PV use after CAR T cells are limited. This multicenter retrospective analysis included patients with LBCL who relapsed or progressed after CAR T-cell therapy and subsequently received PV with or without rituximab and bendamustine between July 2019 and May 2021. Response to treatment and progression were assessed based on the 2014 Lugano criteria. Fifty-seven patients were included in the study: 18 (32%) patients were primary refractory to CAR T-cell therapy, and 34 (60%) patients received PV-based therapy immediately after CAR T-cell therapy. PV was combined with rituximab in 54 (95%) patients and administered with bendamustine in 35 (61%) patients. A response was achieved in 25 (44%) patients, including complete remission in 8 (14%). No significant association between baseline characteristics and response was observed. After a median follow-up of 47 weeks (95% confidence interval [CI], 40-54), 46 (81%) patients had disease progression or died, and the median progression-free survival was 10 weeks (95% CI, 5-15). On a multivariate analysis, bone marrow involvement (hazard ratio, 5.2; 95% CI, 1.8-15; P = .003) and elevated lactate dehydrogenase levels (hazard ratio, 5.0; 95% CI, 1.4-16; P = .01) were associated with shorter progression-free survival. Studies aimed at better characterizing the intrinsic mechanism of resistance and identifying optimal consolidation strategies for these patients are warranted.
Invited Commentary–A Decade Later, Has LiSWT Delivered on Its Promise?
Pattillo, C, Trost, Landon

Mayo Clinic

The Journal of Sexual Medicine | March 3, 2022 | Volume: 19 | Issue: 4 | Pages: 543-545

10.1016/j.jsxm.2022.02.001 | PMID 35249839 Get It

Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
Schwartz, Peter J. , Ackerman, Michael J. , Schwartz, Peter J.

Mayo Clinic

European Heart Journal | March 3, 2022 | Volume: 43 | Issue: 22 | Pages: 2096-2102

10.1093/eurheartj/ehac134 | PMID 35301528 Get It

Abstract Proper management of patients affected by genetic disorders causing life-threatening arrhythmias is important for several reasons, including even societal ones, given the predominantly young age of those affected. Incorrect management often has dire consequences, ranging from unnecessary psychologic damage for the patients whose life becomes too limited by the fear of sudden death to equally avoidable tragedies when the entire armamentarium of effective therapies is not fully utilized. In this review, we focus primarily on long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT) and deal specifically with the clinical impact of the most commonly used cardiac sympathetic denervation (CSD), namely left cardiac sympathetic denervation (LCSD). The two of us have used LCSD in the management of our patients with either LQTS or CPVT for a very long time and have been involved in ∼500 such interventions. It is on the basis of this personal and direct experience that we wish to share our views with clinical cardiologists and electrophysiologists, adult and paediatric, and with genetic cardiologists. We will begin by reviewing the history and rationale underlying sympathetic denervation therapy and will continue with a disease-specific intensification of therapy, and then with a discussion on how the impressive efficacy of LCSD should translate into guideline-directed therapy in both current and future guidelines, in order to upgrade the quality of care in the era of precision medicine.
Real-World Incidence of Breakthrough Coronavirus Disease 2019 Hospitalization After Vaccination vs Natural Infection in a Large, Local, Empaneled Primary Care Population Using Time-to-Event Analysis
Pollock, Benjamin D. , Storlie, Curtis B. , Sampathkumar, Priya , Pollock, Benjamin D , Tande, Aaron J.

Mayo Clinic

Clinical Infectious Diseases | March 3, 2022 | Volume: 75 | Issue: 7 | Pages: 1239-1241

10.1093/cid/ciac186 | PMID 35247261 Get It

Abstract We followed 106 349 primary care patients for 22 385 3099 person-days across 21 calendar months and documented 69 breakthrough coronavirus disease 2019 (COVID-19) hospitalizations: 65/102,613 (0.06%) among those fully vaccinated, 3/11 047 (0.03%) among those previously infected, and 1/7,313 (0.01%) among those with both statuses. These data give providers real-world context regarding breakthrough COVID-19 hospitalization risk.
Biomedical Imaging Analysis and Mesh Generation for Three-Dimensional Finite Element Models
Ehnes, Dale L., Stone, J.J., An, Kai‐Nan

Mayo Clinic

Advances in Bioengineering | March 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 257-258

10.1115/imece1997-0326 Get It

Abstract The methodological procedure for generating three-dimensional (3-D) finite element analysis (FEA) geometry models from CT or MRI medical imaging scan data was developed in this study. Medical images of a human scapula and a fifth proximal phalangeal bone were used to demonstrate the techniques of image processing and generation of 3-D FEA models. The biomedical imaging quality and its effects on the outcome of the FEA geometry model was also studied.
Letter to the editor: “Oral mini‐pulse therapy in vitiligo: A systematic review”
Chávez‐Álvarez, Sonia , Raygoza‐Cortez, Ana Karina, Suro‐Santos, Yeudiel , Villarreal‐Martínez, Alejandra , Raygoza-Cortez, Karina , Raygoza-Cortez, Ana Karina, Alvarez-Villalobos, Neri Alejandro, Herz‐Ruelas, Maira Elizabeth , Ocampo‐Candiani, Jorge , Álvarez‐Villalobos, Neri Alejandro

Mayo Clinic

International Journal of Dermatology | March 3, 2022 | Volume: 61 | Issue: 7 | Pages: No page available

10.1111/ijd.16135 | PMID 35239974 Get It

So Shines a Good Deed in a Weary World
Heimbach, Julie K., Taner, Timucin, Heimbach, Julie K., Taner, Timucin

Mayo Clinic

Transplantation | March 3, 2022 | Volume: 106 | Issue: 8 | Pages: 1520-1521

10.1097/tp.0000000000004066 | PMID 35238855 Get It

Gene fusions in gastrointestinal tract cancers
Rahi, Hamed, Olave, Maria C. , Fritchie, Karen , Greipp, Patricia T. , Halling, Kevin C. , Kipp, Benjamin R. , Greipp, Patricia T , Graham, Rondell P.

Mayo Clinic

Genes, Chromosomes and Cancer | March 3, 2022 | Volume: 61 | Issue: 5 | Pages: 285-297

10.1002/gcc.23035 | PMID 35239225 Get It

AbstractFusion genes have been identified in a wide array of human neoplasms including hematologic and solid tumors, including gastrointestinal tract neoplasia. A fusion gene is the product of parts of two genes that are joined together following a deletion, translocation, or chromosomal inversion. Together with single nucleotide variants, insertions, deletions, and amplification, fusion genes represent one of the key genomic mechanisms for tumor development. Detecting fusions in the clinic is accomplished by a variety of techniques including break‐apart fluorescence in situ hybridization, reverse transcription‐polymerase chain reaction, and next‐generation sequencing. Some recurrent gene fusions have been successfully targeted by small molecule or monoclonal antibody therapies (ie targeted therapies), while others are used as biomarkers for diagnostic and prognostic purposes. The purpose of this review article is to discuss the clinical utility of detection of gene fusions in carcinomas and neoplasms arising primarily in the digestive system.
Electromechanical reciprocity and arrhythmogenesis in long-QT syndrome and beyond
Odening, Katja E. , Linde, Henk J. van der, Ackerman, Michael J. , Bekke, Rachel M.A. ter , Odening, Katja E , Volders, Paul G.A.

Mayo Clinic

European Heart Journal | March 3, 2022 | Volume: 43 | Issue: 32 | Pages: 3018-3028

10.1093/eurheartj/ehac135 | PMID 35445703 Get It

Abstract An abundance of literature describes physiological and pathological determinants of cardiac performance, building on the principles of excitation–contraction coupling. However, the mutual influencing of excitation–contraction and mechano-electrical feedback in the beating heart, here designated ‘electromechanical reciprocity’, remains poorly recognized clinically, despite the awareness that external and cardiac-internal mechanical stimuli can trigger electrical responses and arrhythmia. This review focuses on electromechanical reciprocity in the long-QT syndrome (LQTS), historically considered a purely electrical disease, but now appreciated as paradigmatic for the understanding of mechano-electrical contributions to arrhythmogenesis in this and other cardiac conditions. Electromechanical dispersion in LQTS is characterized by heterogeneously prolonged ventricular repolarization, besides altered contraction duration and relaxation. Mechanical alterations may deviate from what would be expected from global and regional repolarization abnormalities. Pathological repolarization prolongation outlasts mechanical systole in patients with LQTS, yielding a negative electromechanical window (EMW), which is most pronounced in symptomatic patients. The electromechanical window is a superior and independent arrhythmia-risk predictor compared with the heart rate-corrected QT. A negative EMW implies that the ventricle is deformed—by volume loading during the rapid filling phase—when repolarization is still ongoing. This creates a ‘sensitized’ electromechanical substrate, in which inadvertent electrical or mechanical stimuli such as local after-depolarizations, after-contractions, or dyssynchrony can trigger abnormal impulses. Increased sympathetic-nerve activity and pause-dependent potentiation further exaggerate electromechanical heterogeneities, promoting arrhythmogenesis. Unraveling electromechanical reciprocity advances the understanding of arrhythmia formation in various conditions. Real-time image integration of cardiac electrophysiology and mechanics offers new opportunities to address challenges in arrhythmia management.
Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma
Villa, Nancy , Mamola, Joseph, Sharik, Meaghen E. , Matos, Ana Lemos de , Lowe, Kenneth , D’Isabella, Julia, Goras, Elizabeth, Chesi, Marta , Bergsagel, P. Leif , McFadden, Grant , Bergsagel, P. Leif , Rahman, Masmudur M. , Kilbourne, Jacquelyn A. , Daggett-Vondras, Juliane

Mayo Clinic

Oncotarget | March 3, 2022 | Volume: 13 | Issue: 1 | Pages: 490-504

10.18632/oncotarget.28205 | PMID 35251496 Get It